血管支架的全球市場:現狀分析·預測(2021年～2027年)

全球血管支架的市場規模在2021年～2027年的預測期間內預計將以約7％的年複合成長率成長。

血管支架技術的進步伴隨著心血管疾病和心力衰竭患病率的上升。兒童和青少年生活方式偏好的改變促使肥胖和糖尿病等可促使心臟病發作的疾病增加，從而促使血管支架的市場增長。不斷增長的老年人口也促使心臟病的增加，從而促使對血管支架的需求增加。

本報告提供全球血管支架市場相關調查，提供市場摘要，市場收益，產品·類型·傳送模式·終端用戶·各地區的市場洞察，市場動態，機會，企業簡介等相關資訊。

目錄

第1章 市場簡介

第2章 調查手法·前提條件

• 血管支架市場調查流程
• 血管支架市場調查手法
• 預測手法
• 受訪者簡介
• 血管支架市場調查的主要目的

第3章 市場摘要

第4章 摘要整理

第5章 全球血管支架市場上COVID-19影響

第6章 全球血管支架市場收益，2019年～2027年F

第7章 市場洞察:各產品

• 冠狀動脈支架
• 末梢支架
• EVAR血管支架
• 其他

第8章 市場洞察:各類型

• 傳統金屬支架
• 藥物釋放型性支架
• 生物可吸收支架

第9章 市場洞察:各傳送模式

• 球囊擴張型支架
• 自動擴張型支架

第10章 市場洞察:各終端用戶

• 醫院·診所
• 門診病人手術中心
• 其他

第11章 市場洞察:各地區

• 北美
  • 美國
  • 加拿大
  • 其他的北美
• 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 其他的歐洲
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 其他的亞太地區
• 其他地區

第12章 血管支架市場:市場動態

• 推動市場要素
• 市場課題
• 影響分析

第13章 血管支架市場:機會

第14章 血管支架市場:趨勢

第15章 法律·法律規範

第16章 需求面·供給面分析

• 需求面分析
• 供給面分析

第17章 價值鏈分析

第18章 競爭模式

• 波特的五力分析

第19章 企業簡介

• Abbott
• Medtronic
• Boston Scientific Corporation
• Terumo Corporation
• B Braun Melsungen AG
• Biotronik
• Stentys SA
• MicroPort Scientific Corporation
• C. R. Bard Inc.
• Cook Medical

第20章 免責聲明

Global Vascular Stent Market is anticipated to grow with an elevated CAGR of around 7% over the forecast period (2021-2027). The technological advancements in vascular stents are accompanied by the increasing prevalence of cardiovascular diseases and heart failure. Furthermore, the changing lifestyle preferences in children and adolescents are responsible for the rising number of diseases such as obesity and diabetes that can cause heart attacks are also responsible for the growth of the vascular stent market. For instance, as per CDC, the prevalence of obesity was 19.7% and affected about 14.7 million children and adolescents. Obesity prevalence was 12.7% among 2 to 5-year-olds, 20.7% among 6 to 11-year-olds, and 22.2% among 12 to 19-year-olds. Moreover, the rising geriatric population is also responsible for the rising cardiac disorders that result in rising demand for the vascular stent.

Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, C. R. Bard, Inc., and Cook Medical are some of the key players operating in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new varieties of vascular stent.

 

Insights Presented in the Report:

"Amongst Type, drug-eluting stents segment holds the major share"

Based on the type, the market is categorized into bare-metal stents, drug-eluting stents, and bioabsorbable stents. The drug-eluting stents segment held a significant market in 2020 and it is anticipated to grow during the forecast period. The rapidly increasing number of cases of coronary heart disease induces the demand for a better and improved version of the stents responsible for the segmental growth of drug-eluting stents. Furthermore, frequent launches of new-generation stents are responsible for the segmental growth of drug-eluting stents. For instance, in May 2022, Medtronic plc, announced it received U.S. Food and Drug Administration (FDA) approval for the Onyx Frontier™ drug-eluting stent (DES). Onyx Frontier DES leverages the same best-in-class stent platform as Resolute Onyx™ DES, with an enhanced delivery system designed to improve deliverability and increase acute performance in even the most challenging of cases.

"Amongst Mode of Delivery, balloon-expandable stents held the major share"

Based on the mode of delivery, the market is segmented into balloon-expandable stents and self-expanding stents. The balloon-expandable stents held a significant market share and are anticipated to witness significant growth during the forecast period. This is mainly due to the increasing complexity of heart surgeries and their accuracy during the stent placement. Furthermore, the advancement in stent technology also favors the growth of the segment in the vascular stent market. For instance, in November 2021, the Robert Wood Johnson University Hospital treated a patient with the new drug-coated balloon angioplasty therapy named AGENT™ Drug-Coated Balloon (DCB), a minimally invasive coronary angioplasty balloon catheter, to treat a 77-year-old patient whose artery had repeatedly narrowed again after several previous angioplasty treatments with drug-eluting stents.

"Amongst End-users, hospitals & clinics holds the major share"

Based on end-user, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics are predicted to have considerable market growth during the forecast period. This is due to the specialization in heart disease treatments along with the presence of specialized staff. Furthermore, the integration of advanced technology such as AI-based equipment and electronic patient records attributes to the growth of the hospitals and clinics in the vascular stent market. For instance, ClinOme is a Graphical User Interface (GUI) based automated tool developed by senior scientists & clinicians from ACTREC & Tata Memorial Hospital. It automates quality check, primary, secondary and tertiary analysis of raw NGS data followed by report generation that can be easily comprehended by the clinicians.

"North America represents one of the largest markets of vascular stent market"

For a better understanding of the market adoption of the vascular stent, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America grabbed a significant market share of the global vascular stent market in 2020. It is expected to grow with a considerable CAGR during the forecast period. The major factors such as sophisticated healthcare infrastructure, the presence of a large population, the rise in cardiac disease incidence, the aging population, the rising prevalence of peripheral arterial disease, and increasing investments by investors are propelling the growth of this market. For instance, as per CDC, approximately 8 million people in the United States have peripheral arterial disease, including 12-20% of individuals older than age 60.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

The global vascular stent market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Global Vascular Stent Market is anticipated to grow with an elevated CAGR of around 7% over the forecast period (2021-2027). The technological advancements in vascular stents are accompanied by the increasing prevalence of cardiovascular diseases and heart failure. Furthermore, the changing lifestyle preferences in children and adolescents are responsible for the rising number of diseases such as obesity and diabetes that can cause heart attacks are also responsible for the growth of the vascular stent market. For instance, as per CDC, the prevalence of obesity was 19.7% and affected about 14.7 million children and adolescents. Obesity prevalence was 12.7% among 2 to 5-year-olds, 20.7% among 6 to 11-year-olds, and 22.2% among 12 to 19-year-olds. Moreover, the rising geriatric population is also responsible for the rising cardiac disorders that result in rising demand for the vascular stent.

Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, C. R. Bard, Inc., and Cook Medical are some of the key players operating in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new varieties of vascular stent.

 

Insights Presented in the Report:

"Amongst Type, drug-eluting stents segment holds the major share"

Based on the type, the market is categorized into bare-metal stents, drug-eluting stents, and bioabsorbable stents. The drug-eluting stents segment held a significant market in 2020 and it is anticipated to grow during the forecast period. The rapidly increasing number of cases of coronary heart disease induces the demand for a better and improved version of the stents responsible for the segmental growth of drug-eluting stents. Furthermore, frequent launches of new-generation stents are responsible for the segmental growth of drug-eluting stents. For instance, in May 2022, Medtronic plc, announced it received U.S. Food and Drug Administration (FDA) approval for the Onyx Frontier™ drug-eluting stent (DES). Onyx Frontier DES leverages the same best-in-class stent platform as Resolute Onyx™ DES, with an enhanced delivery system designed to improve deliverability and increase acute performance in even the most challenging of cases.

"Amongst Mode of Delivery, balloon-expandable stents held the major share"

Based on the mode of delivery, the market is segmented into balloon-expandable stents and self-expanding stents. The balloon-expandable stents held a significant market share and are anticipated to witness significant growth during the forecast period. This is mainly due to the increasing complexity of heart surgeries and their accuracy during the stent placement. Furthermore, the advancement in stent technology also favors the growth of the segment in the vascular stent market. For instance, in November 2021, the Robert Wood Johnson University Hospital treated a patient with the new drug-coated balloon angioplasty therapy named AGENT™ Drug-Coated Balloon (DCB), a minimally invasive coronary angioplasty balloon catheter, to treat a 77-year-old patient whose artery had repeatedly narrowed again after several previous angioplasty treatments with drug-eluting stents.

"Amongst End-users, hospitals & clinics holds the major share"

Based on end-user, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics are predicted to have considerable market growth during the forecast period. This is due to the specialization in heart disease treatments along with the presence of specialized staff. Furthermore, the integration of advanced technology such as AI-based equipment and electronic patient records attributes to the growth of the hospitals and clinics in the vascular stent market. For instance, ClinOme is a Graphical User Interface (GUI) based automated tool developed by senior scientists & clinicians from ACTREC & Tata Memorial Hospital. It automates quality check, primary, secondary and tertiary analysis of raw NGS data followed by report generation that can be easily comprehended by the clinicians.

"North America represents one of the largest markets of vascular stent market"

For a better understanding of the market adoption of the vascular stent, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America grabbed a significant market share of the global vascular stent market in 2020. It is expected to grow with a considerable CAGR during the forecast period. The major factors such as sophisticated healthcare infrastructure, the presence of a large population, the rise in cardiac disease incidence, the aging population, the rising prevalence of peripheral arterial disease, and increasing investments by investors are propelling the growth of this market. For instance, as per CDC, approximately 8 million people in the United States have peripheral arterial disease, including 12-20% of individuals older than age 60.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

The global vascular stent market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Limitation
• 1.3. Stakeholders
• 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Vascular Stent Market
• 2.2. Research Methodology of the Vascular Stent Market
• 2.3. Forecasting Method
• 2.4. Respondent Profile
• 2.5. Main Objective of the Vascular Stent Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL VASCULAR STENT MARKET COVID-19 IMPACT

6 GLOBAL VASCULAR STENT MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT

• 7.1. Coronary Stent
• 7.2. Peripheral Stent
• 7.3. EVAR Stent Grafts
• 7.4. Others

8 MARKET INSIGHTS BY TYPE

• 8.1. Bare-metal Stents
• 8.2. Drug-eluting Stents
• 8.3. Bioabsorbable Stents

9 MARKET INSIGHTS BY MODE OF DELIVERY

• 9.1. Balloon-expandable Stents
• 9.2. Self-expanding Stents

10 MARKET INSIGHTS BY END-USERS

• 10.1. Hospitals & Clinics
• 10.2. Ambulatory Surgical Centers
• 10.3. Others

11 MARKET INSIGHTS BY REGION

• 11.1. North America
  • 11.1.1. United States
  • 11.1.2. Canada
  • 11.1.3. Rest of North America
• 11.2. Europe
  • 11.2.1. Germany
  • 11.2.2. France
  • 11.2.3. U.K.
  • 11.2.4. Italy
  • 11.2.5. Spain
  • 11.2.6. Rest of Europe
• 11.3. Asia Pacific
  • 11.3.1. China
  • 11.3.2. Japan
  • 11.3.3. India
  • 11.3.4. Australia
  • 11.3.5. Rest of Asia Pacific
• 11.4. Rest of World

12 VASCULAR STENT MARKET DYNAMICS

• 12.1. Market Drivers
• 12.2. Market Challenges
• 12.3. Impact Analysis

13 VASCULAR STENT MARKET OPPORTUNITIES

14 VASCULAR STENT MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY-SIDE ANALYSIS

• 16.1. Demand Side Analysis
• 16.2. Supply Side Analysis

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

• 18.1. Porter's Five Forces Analysis

19 COMPANY PROFILED

• 19.1. Abbott
• 19.2. Medtronic
• 19.3. Boston Scientific Corporation
• 19.4. Terumo Corporation
• 19.5. B Braun Melsungen AG
• 19.6. Biotronik
• 19.7. Stentys SA
• 19.8. MicroPort Scientific Corporation
• 19.9. C. R. Bard Inc.
• 19.10. Cook Medical

20 DISCLAIMER